Novartis’ Chinook-originated kidney disease drug gets accelerated approvalnews2025-04-03T11:36:16+00:00April 3rd, 2025|Endpoints News|
Sarepta, Roche pause Elevidys trials in Europe following patient deathnews2025-04-03T11:11:47+00:00April 3rd, 2025|Endpoints News|
Exclusive: Neurona bags $102M to treat epilepsy with cell therapynews2025-04-03T10:00:15+00:00April 3rd, 2025|Endpoints News|
Trump’s tariff rollout leaves many questions for drugmakersnews2025-04-03T00:08:58+00:00April 3rd, 2025|Endpoints News|
Trump’s tariffs could leave the pharma industry scramblingnews2025-04-02T20:48:38+00:00April 2nd, 2025|Endpoints News|
Biopharma execs rethink Trump impact after FDA cutsnews2025-04-02T19:47:10+00:00April 2nd, 2025|Endpoints News|
New FDA Commissioner Marty Makary addresses staff a day after firingsnews2025-04-02T18:21:25+00:00April 2nd, 2025|Endpoints News|
Eli Lilly adds obesity startup knownwell to its direct-to-consumer servicenews2025-04-02T16:55:45+00:00April 2nd, 2025|Endpoints News|
BIO CEO on tariffs, MAHA and the future of the biotech industrynews2025-04-02T15:49:36+00:00April 2nd, 2025|Endpoints News|
